SANDU PHARMACEUTICALS LTD. Share Price

SANDU PHARMACEUTICALS LTD. Share Price

BSE: 524703
|
Pharmaceuticals

₹ 34.32

-₹2.13 (-5.84%)
1D
Last updated 13 Oct, 2026, 11:43 IST

SANDU PHARMACEUTICALS LTD. Share Price Today

As of 13 Oct 2026, SANDU PHARMACEUTICALS LTD. share price is ₹34.32. The stock opened at ₹36.00, compared to its previous close of ₹36.45. During today's trading session, SANDU PHARMACEUTICALS LTD. share price moved in the range of ₹34.32 to ₹36.50, with an average price of ₹35.41 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.00 and a high of ₹50.00.

₹34.32
5.84% down today
₹36.50
1D LOW
1D HIGH

SANDU PHARMACEUTICALS LTD. Returns Calculator

Volume
1,459
Average traded price
₹34.82
Last traded time
11:43:59 13 Oct
Last traded quantity
87
Circuit
L
H
₹29.16
₹43.74
52-week
L
H
₹30.00
₹50.00
Mkt Cap Cr
35.22
P/E
30.43
P/B
1.41
ROA
3.65%
ROE
4.74%
ROCE
6.87%
Quick Ratio
1.01
EV/EBITDA
15.24
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Sandu Pharma. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Sandu Pharma. appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Sandu Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,21,539.1634.795.0411.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9884.6414.7714.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.2221.084.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.224.18.57%18.59%17.35%0.9114.87
Laurus Labs1,09,796.85100.720.7210.38%16.77%16.14%0.6853.86
Cipla1,05,289.7831.373.067.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4131.332.625.48%11.07%12.54%1.3515.86
Mankind Pharma97,850.3847.326.07.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.152.566.34%9.25%11.76%1.1512.47
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About SANDU PHARMACEUTICALS LTD.

SANDU PHARMACEUTICALS LTD. Share Price
ISIN
INE751D01014
Sector Market Cap
₹ 35.22 Cr

Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.

SANDU PHARMACEUTICALS LTD. Financial Highlights

  • Revenue: SANDU PHARMACEUTICALS LTD. reported revenue of ₹67.36 crore in FY25 vs ₹67.70 crore in FY24. It showed a decrease of 0.50% on a yearly basis.
  • Operating Profit: SANDU PHARMACEUTICALS LTD. reported an operating profit of ₹2.16 crore in FY25 vs ₹2.07 crore in FY24. It showed an increase of 4.35% on a year-on-year basis.
  • Net Profit: SANDU PHARMACEUTICALS LTD. reported a net profit of ₹1.55 crore in FY25 vs ₹1.46 crore in FY24. It showed an increase of 6.16% on a yearly basis.

SANDU PHARMACEUTICALS LTD. Quarterly Result Highlights

  • SANDU PHARMACEUTICALS LTD. reported revenue of ₹14.14 crore in Mar 2025, compared with ₹18.39 crore in Dec 2024, representing a decrease of 23.11% on a quarter-on-quarter (QoQ) basis.
  • SANDU PHARMACEUTICALS LTD. reported an operating profit of ₹0.34 crore in Mar 2025, compared with ₹0.80 crore in Dec 2024, representing a decrease of 57.50% on a quarter-on-quarter (QoQ) basis.
  • SANDU PHARMACEUTICALS LTD. reported a profit of ₹0.33 crore in Mar 2025, compared with ₹0.56 crore in Dec 2024, reflecting a decrease of 41.07% on a QoQ basis.
  • The earnings per share (EPS) of SANDU PHARMACEUTICALS LTD. stood at ₹1.60 during Mar 2025.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
37.79%
FII
0.00%
Other DII
0.01%
Retail and other
62.21%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
1 day
-0.03%
1 week
-2.20%
1 month
-1.51%
1 year
-18.42%
3 years
-48.94%
5 years
-32.12%
Day
Open / Close
Change %
12 Oct 26
₹36.64 / ₹36.45
-0.03%
09 Oct 26
₹37.29 / ₹36.46
-0.27%
08 Oct 26
₹34.70 / ₹36.56
-0.71%
07 Oct 26
₹37.44 / ₹36.82
+1.83%
Show more

SANDU PHARMACEUTICALS LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Revenue₹67.19₹67.28₹65.35
Other Income₹0.17₹0.42₹0.33
Total Revenue₹67.36₹67.70₹65.68
Total Expenses₹65.20₹65.63₹63.46
Profit Before Tax₹2.16₹2.07₹2.22
Tax₹0.61₹0.61₹0.70
Profit After Tax₹1.55₹1.46₹1.52
EPS - Basic₹1.60₹1.51₹1.62
EPS - Diluted₹1.60₹1.51₹1.62

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Profit before tax₹2.16₹2.07₹2.22
Income before WC changes₹2.86₹2.48₹2.69
Change in Assets-₹2.13₹2.61-₹3.99
Change in Liabilities₹0.80-₹3.83₹2.21
Change in WC-₹1.32-₹1.22-₹1.77
Cash flow from Operations₹0.95₹0.76₹0.22
Cash flow from Investing-₹0.19-₹1.31₹0.54
Cash flow from Financing-₹0.46-₹0.72₹0.58
Total Cash Flow₹0.30-₹1.27₹1.34
Cash (Start of the year)₹1.00₹2.28₹0.94
Cash (End of the year)₹1.30₹1.00₹2.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Non-Current Assets₹29.42₹30.11₹28.62
Current Assets₹26.30₹22.30₹25.55
Total Assets₹55.72₹52.41₹54.17
Current Liabilities₹12.09₹10.64₹13.88
Net Current Asset₹14.21₹11.66₹11.66
Non-Current Liabilities₹1.62₹1.18₹1.04
Equity Capital₹42.02₹40.59₹39.24
Total Equity & Liabilities₹55.72₹52.41₹54.17

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹69.93₹67.19₹67.28₹65.35
Other Income₹0.44₹0.17₹0.42₹0.33
Total Revenue₹70.38₹67.36₹67.70₹65.68
Total Expenses₹67.72₹65.20₹65.63₹63.46
Profit Before Tax₹2.66₹2.16₹2.07₹2.22
Tax₹0.89₹0.61₹0.61₹0.70
Profit After Tax₹1.77₹1.55₹1.46₹1.52
EPS - Basic₹1.83₹1.60₹1.51₹1.62
EPS - Diluted₹1.83₹1.60₹1.51₹1.62

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2.66₹2.16₹2.07₹2.22
Income before WC changes₹3.65₹2.86₹2.48₹2.70
Change in Assets₹3.10-₹2.13₹2.61-₹3.99
Change in Liabilities₹0.12₹0.80-₹3.83₹2.21
Change in WC₹3.22-₹1.32-₹1.22-₹1.78
Cash flow from Operations₹6.12₹0.95₹0.76₹0.22
Cash flow from Investing-₹0.57-₹0.18-₹1.31₹0.53
Cash flow from Financing-₹0.94-₹0.46-₹0.72₹0.58
Total Cash Flow₹4.60₹0.31-₹1.27₹1.33
Cash (Start of the year)₹1.30₹1.00₹2.27₹0.94
Cash (End of the year)₹5.91₹1.30₹1.00₹2.27

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹30.55₹29.42₹30.12₹28.63
Current Assets₹25.32₹26.30₹22.30₹25.54
Total Assets₹55.87₹55.72₹52.42₹54.17
Current Liabilities₹10.42₹12.09₹10.64₹13.88
Net Current Asset₹14.90₹14.21₹11.66₹11.66
Non-Current Liabilities₹1.77₹1.62₹1.18₹1.04
Equity Capital₹43.67₹42.02₹40.60₹39.24
Total Equity & Liabilities₹55.87₹55.72₹52.42₹54.17
* All values are in INR Crore
Qty
Bid
87
34.32
25
34.31
1
34.3
1
34
100
33.69
Ask
Qty
35
10
36.4
187
36.49
10
36.5
188
36.55
91
Bid Total: 214
Ask Total: 486
Buy orders: 31%
Sell orders: 69%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
44.88
Neutral
ATR (14)
1.94
Neutral
STOCH(9,6)
61.25
Neutral
STOCH RSI (14)
61.76
Neutral
ADX(9)
17.61
Bullish
UO(9)
60.57
Neutral
ROC(12)
-1.75
Bearish
WillR(14)
-43.68
Neutral
Period
Simple value
Exponential vaue
5D
36.49
36.52
10D
36.48
36.61
20D
36.76
36.85
50D
37.67
37.66
100D
39.43
38.19
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
6 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SANDU PHARMACEUTICALS LTD. Share Price
SANDU PHARMACEUTICALS LTD.
Pharmaceuticals
Add Stock
Add Another

SANDU PHARMACEUTICALS LTD. Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.